APA (7th ed.) Citation

Liu, S., Chen, L., Chen, P., Huang, M., Liu, T., Peng, J., & Lu, X. (2022). PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: With the involvement of the HDAC3/microRNA-195-5p/SGK1. Clinical Epigenetics, 14(1), 1. https://doi.org/10.1186/s13148-022-01336-1

Chicago Style (17th ed.) Citation

Liu, Shu-cheng, Li-bo Chen, Ping-feng Chen, Meng-long Huang, Tian-pei Liu, Jun Peng, and Xin-sheng Lu. "PDCD5 Inhibits Progression of Renal Cell Carcinoma by Promoting T Cell Immunity: With the Involvement of the HDAC3/microRNA-195-5p/SGK1." Clinical Epigenetics 14, no. 1 (2022): 1. https://doi.org/10.1186/s13148-022-01336-1.

MLA (9th ed.) Citation

Liu, Shu-cheng, et al. "PDCD5 Inhibits Progression of Renal Cell Carcinoma by Promoting T Cell Immunity: With the Involvement of the HDAC3/microRNA-195-5p/SGK1." Clinical Epigenetics, vol. 14, no. 1, 2022, p. 1, https://doi.org/10.1186/s13148-022-01336-1.